Alcohol consumption and depressive symptoms over time: A longitudinal study of patients with and without HIV infection

Drug and Alcohol Dependence

Volumn 117, Issue 2-3, 2011, Pages 158-163

  Sullivan, Lynn E ^a   Goulet, Joseph L ^a,b   Justice, Amy C ^a,b   Fiellin, David A ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

Author keywords

Acquired immunodeficiency syndrome; Alcohol drinking; Alcoholism; Depression; Depressive disorder; HIV

Indexed keywords

ANTIRETROVIRUS AGENT; SEROTONIN UPTAKE INHIBITOR;

ADULT; AGED; ALCOHOL ABUSE; ALCOHOL CONSUMPTION; ALCOHOLISM; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DEPRESSION; DISEASE ASSOCIATION; DISEASE SEVERITY; DRINKING BEHAVIOR; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SYMPTOM;

ADULT; AGED; AGED, 80 AND OVER; ALCOHOL DRINKING; ALCOHOLISM; COHORT STUDIES; DATA COLLECTION; DEPRESSION; FEMALE; HIV INFECTIONS; HOSPITALS, VETERANS; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PSYCHIATRIC STATUS RATING SCALES; SUBSTANCE-RELATED DISORDERS; UNITED STATES; YOUNG ADULT;

EID: 79960844093     PISSN: 03768716     EISSN: 18790046     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2011.01.014     Document Type: Article

References (49)

1. Anon., 1978. Commission on Professional and Hospital Activities: The International Classification of Diseases, 9th Revision, Clinical Modification, (ICD-9-CM), Ann Arbor, MI.
2. Anon., 1993. Depression in Primary Care: Detection and Diagnosis, vol. 1, Clinical Practice Guideline No. 5 Depression Guideline Panel. U.S. Department of Health and Human Services, Rockville, MD.
3. Anton R.F., O'Malley S.S., Ciraulo D.A., Cisler R.A., Couper D., Donovan D.M., Gastfriend D.R., Hosking J.D., Johnson B.A., LoCastro J.S., Longabaugh R., Mason B.J., Mattson M.E., Miller W.R., Pettinati H.M., Randall C.L., Swift R., Weiss R.D., Williams L.D., Zweben A., Group C.S.R. Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial. JAMA 2006, 295:2003-2017.
4. Bagasra O., Kajdacsy-Balla A., Lischner H.W. Effects of alcohol ingestion on in vitro susceptibility of peripheral blood mononuclear cells to infection with HIV and of selected T-cell functions. Alcohol. Clin. Exp. Res. 1989, 13:636-643.
5. Braithwaite R.S., Kozal M.J., Chang C.C., Roberts M.S., Fultz S.L., Goetz M.B., Gibert C., Rodriguez-Barradas M., Mole L., Justice A.C. Adherence, virological and immunological outcomes for HIV-infected veterans starting combination antiretroviral therapies. AIDS 2007, 21:1579-1589.
6. Brown J., Kranzler H.R., Del Boca F.K. Self-reports by alcohol and drug abuse inpatients: factors affecting reliability and validity. Br. J. Addict. 1992, 87:1013-1024.
7. Cook R.L., Sereika S.M., Hunt S.C., Woodward W.C., Erlen J.A., Conigliaro J. Problem drinking and medication adherence among persons with HIV infection. J. Gen. Intern. Med. 2001, 16:83-88.
8. Cook R.T., Stapleton J.T., Ballas Z.K., Klinzman D. Effect of a single ethanol exposure on HIV replication in human lymphocytes. J. Investig. Med. 1997, 45:265-271.
9. Cruess D.G., Petitto J.M., Leserman J., Douglas S.D., Gettes D.R., Ten Have T.R., Evans D.L. Depression and HIV infection: impact on immune function and disease progression. CNS Spectr. 2003, 8:52-58.
10. Edlund M.J., Booth B.M., Feldman Z.L. Perceived need for treatment for alcohol use disorders: results from two national surveys. Psychiatr. Serv. 2009, 60(12):1618-1628.
11. Evans D.L., Ten Have T.R., Douglas S.D., Gettes D.R., Morrison M., Chiappini M.S., Brinker-Spence P., Job C., Mercer D.E., Wang Y.L., Cruess D.G., Dube B., Dalen E.A., Brown T., Bauer R., Pettito J.M. Association of depression with viral load, CD8 T lymphocytes, and natural killer cells in women with HIV infection. Am. J. Psychiatry 2002, 159:1752-1759.
12. Fabris P., Tositti G., Manfrin V., Giordani M.T., Vaglia A., Cattelan A.M., Carlotto A. Does alcohol intake affect highly active antiretroviral therapy (HAART) response in HIV-positive patients?. J. Acquir. Immune Defic. Syndr. 2000, 25:92-93.
13. Fergusson D.M., Boden J.M., Horwood L.J. Tests of causal links between alcohol abuse or dependence and major depression. Arch. Gen. Psychiatry 2009, 66:260-266.
14. Fleming M.F., Manwell L.B., Barry K.L., Johnson K. At-risk drinking in an HMO primary care sample: prevalence and health policy implications. Am. J. Public Health 1998, 88:90-93.
15. Galvan F.H., Bing E.G., Fleishman J.A., London A.S., Caetano R., Burnam M.A., Longshore D., Morton S.C., Orlando M., Shapiro M. The prevalence of alcohol consumption and heavy drinking among people with HIV in the United States: results from the HIV Cost and Services Utilization Study. J. Stud. Alcohol 2002, 63:179-186.
16. Gual A., Segura L., Contel M., Heather N., Colom J. Audit-3 and audit-4: effectiveness of two short forms of the alcohol use disorders identification test. Alcohol Alcohol. 2002, 37:591-596.
17. Halme J.T., Seppä K., Alho H., Pirkola S., Poikolainen K., Lönnqvist J., Aalto M. Hazardous drinking: Prevalence and associations in the Finnish general population. Alcohol. Clin. Exp. Res. 2008, 32:1615-1621.
18. Harman J.S., Veazie P.J., Lyness J.M. Primary care physician office visits for depression by older Americans. J. Gen. Intern. Med. 2006, 21:926-930.
19. Hasin D.S., Stinson F.S., Ogburn E., Grant B.F. Prevalence, correlates, disability, and comorbidity of DSM-IV alcohol abuse and dependence in the United States: results from the national epidemiologic survey on alcohol and related conditions. Arch. Gen. Psychiatry 2007, 64(7):830-842.
20. Hasin D.S., Grant B.F. Major depression in 6050 former drinkers association with past alcohol dependence. Arch. Gen. Psychiatry 2002, 59:794-800.
21. Hesselbrock M., Babor T.F., Hesselbrock V., Meyer R.E., Workman K. " Never believe an alcoholic" ? On the validity of self-report measures of alcohol dependence and related constructs. Int. J. Addict. 1983, 18:593-609.
22. Justice A.C., Dombrowski E., Conigliaro J., Fultz S.L., Gibson D., Madenwald T., Goulet J., Simberkoff M., Butt A.A., Rimland D., Rodriguez-Barradas M.C., Gibert C.L., Oursler K.A.K., Brown S., Leaf D.A., Goetz M.B., Bryant K. Veterans Aging Cohort Study (VACS): overview and description. Med. Care 2006, 44:S13-S24.
23. Justice A.C., Dombrowski E., Conigliaro J., Fultz S.L., Gibson D., Madenwald T., Goulet J., Simberkoff M., Butt A.A., Rimland D., Rodriguez-Barradas M.C., Gibert C.L., Oursler K.K., Brown S., Leaf D.A., Goetz M.B., Bryant K. Veterans aging cohort study (VACS): overview and description. Med. Care 2006, 44:S12-S24.
24. Katon W., Robinson P., Von Korff M., Lin E., Bush T., Ludman E., Simon G., Walker E. A multifaceted intervention to improve treatment of depression in primary care. Arch. Gen. Psychiatry 1996, 53:924-932.
25. Katon W., Von Korff M., Lin E., Walker E., Simon G.E., Bush T., Robinson P., Russo J. Collaborative management to achieve treatment guidelines. Impact on depression in primary care. JAMA 1995, 273:1026-1031.
26. Katz S.J., Kessler R.C., Lin E., Wells K.B. Medication management of depression in the United States and Ontario. J. Gen. Intern. Med. 1998, 13:77-85.
27. Kessler R.C., Berglund P., Demler O., Jin R., Koretz D., Merikangas K.R., Rush A.J., Walters E.E., Wang P.S., National Comorbidity Survey R. The epidemiology of major depressive disorder: results from the national comorbidity survey replication (NCS-R). JAMA 2003, 289:3095-3105.
28. Kranzler H.R. Medications for alcohol dependence - new vistas. JAMA 2000, 284:1016-1017.
29. Kroenke K.R., Spitzer L., Williams J.B. The PHQ-9: validity of a brief depression severity measure. J. Gen. Intern. Med. 2001, 16:606-613.
30. Landon B.E., Wilson I.B., Wenger N.S., Cohn S.E., Fichtenbaum C.J., Bozzette S.A., Shapiro M.F., Cleary P.D. Specialty training and specialization among physicians who treat HIV/AIDS in the United States. J. Gen. Intern. Med. 2002, 17:12-22.
31. Lefevre F., O'Leary B., Moran M., Mossar M., Yarnold P.R., Martin G.J., Glassroth J. Alcohol consumption among HIV-infected patients. J. Gen. Intern. Med 1995, 10:458-460.
32. Leserman J. HIV disease progression: depression, stress, and possible mechanisms. Biol. Psychiatry 2003, 54:295-306.
33. Martinotti G., Nicola M.D., Reina D., Andreoli S., Foca F., Cunniff A., Tonioni F., Bria P., Janiri L. Alcohol protracted withdrawal syndrome: the role of anhedonia. Subst. Use Misuse 2008, 43(3-4):271-284.
34. Muthen B.O. A general structural equation model with dichotomous, ordered categorical, and continuous latent variable indicators. Psychometrika 1984, 49:115-132.
35. Palepu A., Horton N.J., Tibbetts N., Meli S., Samet J.H. Uptake and adherence to highly active antiretroviral therapy among HIV-infected people with alcohol and other substance use problems: the impact of substance abuse treatment. Addiction 2004, 99:361-368.
36. Petry N.M. Alcohol use in HIV patients: what we don't know may hurt us. Int. J. STD AIDS 1999, 10:561-570.
37. Phillips S.J., Freedberg K.A., Traphagen E.T., Horton N.J., Samet J.H. Screening for alcohol problems in HIV-infected primary care patients. J. Gen. Intern. Med. 2001, 16:165.
38. Pincus H.A., Tanielian T.L., Marcus S.C., Olfson M., Zarin D.A., Thompson J., Magno Zito J. Prescribing trends in psychotropic medications: primary care, psychiatry, and other medical specialties. JAMA 1998, 279:526-531.
39. Saitz R. Clinical practice. Unhealthy alcohol use. New Engl. J. Med. 2005, 352:596-607.
40. Samet J.H., Horton N.J., Meli S., Freedberg K.A., Palepu A. Alcohol consumption and antiretroviral adherence among HIV-infected persons with alcohol problems. Alcohol. Clin. Exp. Res. 2004, 28:572-577.
41. Samet J.H., Horton N.J., Traphagen E.T., Lyon S.M., Freedberg K.A. Alcohol consumption and HIV disease progression: are they related?. Alcohol. Clin. Exp. Res. 2003, 27:862-867.
42. Saunders J.B., Aasland O.G., Babor T.F., de la Fuente J.R., Grant M. Development of the alcohol use disorders identification test (AUDIT): WHO collaborative project on early detection of persons with harmful alcohol consumption. II. Addiction 1993, 88:791-804.
43. Schuckit M.A., Tipp J.E., Bucholz K.K., Nurnberger J.I., Hesselbrock C.M., Crowe R.R., Kramer J. The lifetime rates of 3 major mood disorders and 4 major anxiety disorders in alcoholics and controls. Addiction 1997, 92:1289-1304.
44. Simon G.E., VonKorff M. Recognition, management, and outcomes of depression in primary care. Arch. Fam. Med. 1995, 4:99-105.
45. Srisurapanont M., Jarusuraisin N. Opioid antagonists for alcohol dependence. Cochrane Database Syst. Rev. 2005, CD001867.
46. Sullivan L.E., Fiellin D.A., O'Connor P.G. The prevalence and impact of alcohol problems in major depression: a systematic review. Am. J. Med. 2005, 118:330-341.
47. Sullivan L.E., Saitz R., Cheng D.M., Libman H., Nunes D., Samet J.H. The impact of alcohol use on depressive symptoms in HIV-infected patients. Addiction 2008, 103:1461-1467.
48. Turner B.J., Laine C., Cosler L., Hauck W.W. Relationship of gender, depression, and health care delivery with antiretroviral adherence in HIV-infected drug users. J. Gen. Intern. Med. 2003, 18:248-257.
49. U.S.Department of Health and Human Services The Physicians' Guide to Helping Patients with Alcohol Problems. U.S. Department of Health and Human Services, P.H.S. 1995, National Institutes of Health, National Institute on Alcohol Abuse and Alcoholism, Washington, DC.